Krishnendu Saha

When I look at the European revenue for us, it sounds like UK has grown very fast. Is it because we have started selling NRT out there? And the NRT number which you give out, ₹1,200 crores, can I double that just to get the whole revenue fo r the full year? And the last question on gRevlimid. When we speak to Natco, they say that June, September could be a better quarter in FY26. Does it hold true for us also?

And the NRT, the run rate of ₹1,200 crores, is it that we simply double, that is what the number we get for the full year FY26?

And when do we start selling in the UK all by ourselves? It will be next year, is it?